Publications
- Follow-up of expensive pneumo-oncological treatment of advanced non-small cell lung cancer in the I. line of the TULUNG register in the Czech Republic2013 | Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic2012 | Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Treatment of malignant pleural mesothelioma in the Czech Republic2019 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Monitoring of the expensive pneumooncological first-line treatment of the advanced non-small cell lung cancer in the TULUNG register in the Czech Republic2017 | Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Continuation maintenance therapy with pemetrexed in patients with non-small-cell lung cancer in the Czech Republic2016 | First Faculty of Medicine
- Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic2012 | First Faculty of Medicine, Third Faculty of Medicine
- Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial2003 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Gencitabine plus Cisplatin versus Gemcitabine plus carboplatin in Stage IIIb and IV Non. Small Cell Lung Cancer: A Phase III Randomized TrialPublication without faculty affiliation
- Gemcitabine plus cisplatin(GCis) versus gemcitabine plus carboplatin (GCcarb) in patients with stage IIIB and IV non-small cell lung cancer (NSCLC): a randomised phase-III trialPublication without faculty affiliation
- Gemcitabine plus cisplatin (GCis) versus gemcitabine plus carboplatin (GCarb) in patients wiht stage IIIB and IV non-small-cell lung cancer (NSCLC): final result of Czech Lung Cancer Cooperative Group phase III randomized trialPublication without faculty affiliation
Loading network view...
